Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

PharmacoEconomics2024PMID: 38717708

View on PubMed DOI: 10.1007/s40273-024-01394-8

Authors

Scholte, Mirre; Ramaekers, Bram; Danopoulos, Evangelos; Grimm, Sabine E; Fernandez Coves, Andrea; Tian, Xiaoyu; Debray, Thomas; Chen, Jiongyu; Stirk, Lisa; Croft, Rachel; Joore, Manuela; Armstrong, Nigel